In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Industry (Medical Devices, Pharmaceutical), By Therapeutic Area (Oncology, Infectious Disease, Hematology), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment

In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Industry (Medical Devices, Pharmaceutical), By Therapeutic Area (Oncology, Infectious Disease, Hematology), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2025 - 2030


Razor Market Growth & Trends

The global razor market size is estimated to reach USD 15.71 billion by 2030, registering a CAGR of 3.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. A booming market for men’s grooming products and increased awareness among consumers related to personal hygiene have driven product demand over the years.

Electric razors segment is expected to witness the fastest growth with a CAGR of 4.6% over the forecast period. Availability of local and international brands, from Philips and Braun to Indian brands like Syska and Nova, is the primary factor driving this segment. In countries like U.K., U.S. and Germany where the personal care industry is booming, demand for such products is bound to grow irrespective of gender.

While men accounted for the dominant share in the overall market, the women consumer category is expected to witness the highest growth over the forecast period. Growing beauty consciousness among the female population and strong influence of changing fashion trends are factors driving this consumer category. Shaving razors offer a non-surgical and cheap alternative, which has increased consumer preference in dermatology and beauty clinics for various treatments.

The online distribution channel segment led the market with the largest revenue share in 2024. Strong established customer base of online stores and apps such as Nykaa, Purplle, and Amazon has significantly contributed to the growth of this segment. Rise in number of internet users, 24/7 availability of products on these platforms, high availability of discounts and offers, and ease of access, are major factors driving product sales through online channels.

The North America market held the largest share of over 31.6% in 2024 and is anticipated to witness steady growth over the next few years owing to the presence of large manufacturers such as P&G. The availability of technologically advanced products in the market and growing awareness regarding grooming has led to high product demand in this region. Increase in the usage of electric trimmers across homes and salons in U.S. for rapid and effective results is one of the key factors contributing to the dominance of the regional market.

Key players operating in the market include The Procter & Gamble Company; Koninklijke Philips N.V.; Edgewell Disposable Company; Harry’s Inc.; Societe BIC S.A. (BIC); Supermax Limited; and Dorco Co. Ltd. These companies have been generating significant revenue in the market, resulting in steady growth. For instance, as per a P&G report for 2017, the net revenue earned by Gillette alone was USD 65.10 billion, with an estimated 9.0% sales in the shave care category.

Razor Market Report Highlights
  • Cartridge razors constituted a share of 37.5% in the total market in 2024 and the segment is projected to exhibit significant growth over the forecast period.
  • In terms of region, North America held the largest share with a revenue share of 31.6% in 2024.
  • APAC is the fastest growing regional market, exhibiting a 4.5% CAGR over the forecast period.
  • Higher preference for cheaper hair removal solutions in countries such as China, India, and Brazil has given product demand a major boost. This can also be attributed to rising purchasing power of consumers in these regions.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis
1.6.2. Bottom-up Approach
1.7. List of Secondary Sources
1.8. List of Abbreviations
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. In Silico Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Cost Efficiency Associated with In silico Clinical Trials Compared to Traditional Clinical Trials
3.2.1.2. Growing Trend of Eliminating/Reducing Animal Testing
3.2.1.3. Increasing Technological Advancement in the In silico Clinical Trials Market
3.2.2. Market restraint analysis
3.2.2.1. Protein Flexibility Issues, Molecule Conformation and Promiscuity May Hinder Accurate Predictions, thus limiting its Adoption
3.2.2.2. Limited Awareness in the Developing Economies
3.3. Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. In Silico Clinical Trials Market: Industry Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global In Silico Clinical Trials Market: Industry Movement Analysis
4.3. Global In Silico Clinical Trials Size & Trend Analysis, by Industry, 2018 to 2030 (USD Million)
4.4. Medical Devices
4.4.1. Medical devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Pharmaceutical
4.5.1. Pharmaceutical market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. In Silico Clinical Trials Market: Therapeutic Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global In Silico Clinical Trials Market: Therapeutic Area Movement Analysis
5.3. Global In Silico Clinical Trials Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Infectious Disease
5.5.1. Infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hematology
5.6.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Cardiology
5.7.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Dermatology
5.8.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Neurology
5.9.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Diabetes
5.10.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Others
5.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. In Silico Clinical Trials Market: Phase Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global In Silico Clinical Trials Market: Phase Movement Analysis
6.3. Global In Silico Clinical Trials Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
6.4. Phase I
6.4.1. Phase I market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Phase II
6.5.1. Phase II market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Phase III
6.6.1. Phase III market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Phase IV
6.7.1. Phase IV market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. In Silico Clinical Trials Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. North America
7.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Competitive scenario
7.3.2.3. Regulatory framework
7.3.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Competitive scenario
7.3.3.3. Regulatory framework
7.3.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Competitive scenario
7.3.4.3. Regulatory framework
7.3.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Regulatory framework
7.4.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Regulatory framework
7.4.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key country dynamics
7.4.7.2. Competitive scenario
7.4.7.3. Regulatory framework
7.4.7.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key country dynamics
7.4.8.2. Competitive scenario
7.4.8.3. Regulatory framework
7.4.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamics
7.4.9.2. Competitive scenario
7.4.9.3. Regulatory framework
7.4.9.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. China
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. South Korea
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Position Analysis, 2024
8.3. Company Profiles
8.3.1. Certara, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Novadiscovery Sas
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Insilico Medicine, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Dassault Systemes SE
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. GNS Healthcare Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. The AnyLogic Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. InSilicoTrials
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Immunetrics Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Nuventra Pharma Sciences
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Abzena Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings